Imprimis Pharma (IMMY)

5.69 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/9/18 *Est.)

Latest Headlines

Harrow Health Announces Fourth Quarter 2018 Financial Results March 12, 2019 4:01 PM - Globe NewsWire Harrow Health to Attend 31st Annual ROTH Conference on March 18, 2019 March 4, 2019 7:01 AM - Globe NewsWire Harrow Health to Announce Fourth Quarter 2018 Financial Results on March 12, 2019 February 28, 2019 7:01 AM - Globe NewsWire Melt Pharmaceuticals Improves Patent Estate for Sublingual Non-Opioid Pain and Sedation Formulations February 13, 2019 7:00 AM - Globe NewsWire Harrow Health Subsidiary, Mayfield Pharmaceuticals, Inc., Acquires Patented Dyspareunia Drug Candidate and Other Intellectual Property February 7, 2019 7:01 AM - Globe NewsWire Harrow Health Announces $11 Million Series A Financing for Melt Pharmaceuticals Subsidiary February 5, 2019 7:00 AM - Globe NewsWire Form 4 HARROW HEALTH, INC. For: Jan 02 Filed by: Kammer Robert J January 3, 2019 5:27 PM - SEC Filing Form 8-K HARROW HEALTH, INC. For: Dec 27 December 31, 2018 7:01 AM - SEC Filing Imprimis Pharmaceuticals, Inc. Completes Name Change to Harrow Health, Inc. December 31, 2018 7:00 AM - Globe NewsWire Full Article List